Clinical predictors of in-hospital mortality in acutely decompensated heart failure-piecing together the outcome puzzle

Congestive Heart Failure

Volumn 14, Issue 3, 2008, Pages 127-134

  Adams Jr , Kirkwood F ^a   Uddin, Nabil ^b   Herbert Patterson, J ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ACUTE DISEASE; BLOOD; BLOOD PRESSURE; HEART FAILURE; HOSPITALIZATION; HUMAN; MORTALITY; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; REGISTER; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYSTOLE; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL;

ACUTE DISEASE; BLOOD PRESSURE; BLOOD UREA NITROGEN; CREATININE; HEART FAILURE; HOSPITAL MORTALITY; HUMANS; PREDICTIVE VALUE OF TESTS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SYSTOLE; TREATMENT OUTCOME;

EID: 53049083659     PISSN: 15275299     EISSN: 17517133     Source Type: Journal    
DOI: 10.1111/j.1751-7133.2008.04641.x     Document Type: Article

References (49)

1. American Heart Association; American Stroke Association. Heart disease and stroke statistics-2004 update. http://www.americanheart.org/downloadable/heart/1072969766940HSStats2004Update.pdf. Accessed June 1, 2005.
2. Alla F, Zannad F, Filippatos G. Epidemiology of acute heart failure syndromes. Heart Fail Rev. 2007;12(2):91-95.
3. Adams KF Jr, Fonarow GC, Emerman CL, et al; ADHERE Scientific Advisory Committee and Investigators. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149:209-216.
4. Cleland JG, Swedberg K, Follath F, et al. The EuroHeart Failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J. 2003;24:442-463.
5. Komajda M, Follath F, Swedberg K, et al. The EuroHeart Failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J. 2003;24:464-474.
6. Nieminen MS, Brutsaert D, Dickstein K, et al; EuroHeart Survey Investigators. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006;27:2725-2736.
7. Zannad F, Mebazaa A, Juilliere Y, et al; EFICA Investigators. Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: the EFICA study. Eur J Heart Fail. 2006;8:697-705.
8. Tavazzi L, Maggioni AP, Lucci D, et al. Nationwide survey on acute heart failure in cardiology ward services in Italy. Eur Heart J. 2006;27:1207-1215.
9. Fonarow GC, Abraham WT, Albert NM, et al. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design. Am Heart J. 2004;148:43-51.
10. Felker GM, Adams KF Jr, Konstam MA, et al. The problem of decompensated heart failure: nomenclature, classification, and risk stratification. Am Heart J. 2003;145(2 suppl):S18-S25.
11. Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail. 2006;12:10-38.
12. Califf RM, Pieper KS, Lee KL, et al. Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial. Circulation. 2000;101(19):2231-2238.
13. Morrow DA, Antman EM, Giugliano RP, et al. A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy. Lancet. 2001;358(9293):1571-1575.
14. Boersma E, Pieper KS, Steyerberg EW, et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segmen elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation. 2000;101(22):2557-2567.
15. Fonarow GC, Adams KF Jr, Abraham WT, et al; ADHERE Scientific Advisory Committee, Study Group, and Investigators. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005;293(5):572-580.
16. Levine SK, Sachs GA, Kin L, et al. A prognostic model for one-year mortality in older adults after hospital discharge. Am J Med. 2007;120:455-460.
17. Lee DS, Austin PC, Rouleau JL, et al. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA. 2003;290:2581-2587.
18. Lee DS, Austin PC, Rouleau JL, et al. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA. 2003;290:2581-2587.
19. Foody JM, Rathore SS, Wang Y, et al. Physician specialty and mortality among elderly patients hospitalized with heart failure. Am J Med. 2005;118:1120-1125.
20. Ko DT, Tu JV, Masoudi FA, et al. Quality of care and outcomes of older patients with heart failure hospitalized in the United States and Canada. Arch Intern Med. 2005;165:2486-2492.
21. Rathore SS, Foody JM, Wang Y, et al. Race, quality of care, and outcomes of elderly patients hospitalized with heart failure. JAMA. 2003;289:2517-2524.
22. Blackledge HM, Tomlinson J, Squire IB. Prognosis for patients newly admitted to hospital with heart failure: survival trends in 12 220 index admissions in Leicestershire 1993-2001. Heart. 2003;89:615-620.
23. Hernandez AF, Velazquez EJ, Solomon SD, et al. Left ventricular assessment in myocardial infarction: the VALIANT registry. Arch Intern Med. 2005;165:2162-2169.
24. Havranek EP, Wolfe P, Masoudi FA, et al. Provider and hospital characteristics associated with geographic variation in the evaluation and management of elderly patients with heart failure. Arch Intern Med. 2004;164:1186-1191.
25. Philbin EF, DiSalvo TG. Prediction of hospital readmission for heart failure: development of a simple risk score based on administrative data. Rev Port Cardiol. 1999;18:855-856.
26. Dries DL, Exner DV, Domanski MJ, et al. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 2000;35:681-689.
27. Hillege HL, Girbes AR, de Kam PJ, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation. 2000;102:203-210.
28. Forman DE, Butler J, Wang Y, et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol. 2004;43:61-67.
29. Butler J, Forman DE, Abraham WT, et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J. 2004;147:331-338.
30. Smith GL, Vaccarino V, Kosiborod M, et al. Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure? J Card Fail. 2003;9:13-25.
31. Klein L, O'Connor CM, Leimberger JD, et al; the OPTIME-CHF Investigators. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure. Circulation. 2005;111:2454-2460.
32. Dzau VJ, Packer M, Lilly LS, et al. Prostaglandins in severe congestive heart failure: relation to activation of the renin-angiotensin system and hyponatremia. N Engl J Med. 1984;310:347-352.
33. Dzau VJ. Renal and circulatory mechanisms in congestive heart failure. Kidney Int. 1987;31:1402-1415.
34. Milo-Cotter O, Adams KF, O'Connor CM, et al. Acute heart failure associated with high admission blood pressure-a distinct vascular disorder? Eur J Heart Fail. 2007;9:178-183.
35. Gheorghiade M, Abraham WT, Albert NM, et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA. 2006;296:2217-2226.
36. Adams KF Jr, Dunlap SH, Sueta CA, et al. Relation between gender, etiology, and survival in patients with symptomatic heart failure. J Am Coll Cardiol. 1996;28:1781-1788.
37. Adams KF Jr, Sueta CA, Gheorghiade M, et al. Gender differences in survival in advanced heart failure: insights from the FIRST study. Circulation. 1999;99:1816-1821.
38. Ghali JK, Krause-Steinrauf HJ, Adams KF, et al. Gender differences in advanced heart failure: insights from the BEST study. J Am Coll Cardiol. 2003;42:2128-2134.
39. Galvao M, Kalman J, DeMarco T, et al. Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the acute decompensated heart failure registry (ADHERE). J Card Fail. 2006;12:100-107.
40. Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342:1077-1084.
41. Felker GM, Benza RL, Chandler AB, et al; OPTIME-CHF Investigators. Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study. J Am Coll Cardiol. 2003;41:997-1003.
42. Felker GM, Gattis WA, Leimberger JD, et al. Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure. Am J Cardiol. 2003;92:625-628.
43. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12,065 patients with new-onset heart failure. Circulation. 2003;107:223-225.
44. Silverberg DS, Wexler D, Sheps D, et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol. 2001;37:1775-1780.
45. Mancini DM, Katz SD, Lang CC, et al. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation. 2003;107:294-299.
46. Philbin EF, Rocco TA, Lindenmuth NW, et al. Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors. Am J Med. 2000;109:605-613.
47. Smith GL, Masoudi FA, Vaccarino V, et al. Outcomes in heart failure with preserved ejection fraction. J Am Coll Cardiol. 2003;41:1510-1518.
48. Yancy CW, Lopatin M, Stevenson LW, et al; ADHERE Scientific Advisory Committee and Investigators. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol. 2006;47:76-84.
49. Lewis RJ. An introduction to classification and regression tree (CART) analysis. http://www.saem.org/download/lewis1.pdf. Accessed June 10, 2005.